Whilst the US and Europe still dominate the contract research outsourcing market and account for the majority of clinical research activities there is an ongoing and growing change with the emergence of regions such as Central and Eastern Europe, Latin America, Asia Pacific India, China as well as the Middle East becoming increasingly important as a preferred location for outsourcing.
This conference will focus on the challenges and benefits of conducting Oncology clinical trials in emerging regions and draw cost/benefit comparisons with that of more established countries.
Topics under discussion will include:
- FDA/EMA data acceptance guidelines
- Patient recruitment
- Reimbursement issues
- Optimising supply and distribution logistics
- Emerging markets regulations/guidelines
- How small pharma can fight for attention as the main centres for emerging region trials reach capacity
This conference will be co-located with the 3rd Cardiovascular Clinical Trials in Emerging Countries.
For details of early registration discounts, please contact me today at email@example.com or by calling +44 (0) 1865 811188.
I look forward to hearing from you.